The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy

Jean‐baptiste Reisqs (1, 2) , Adrien Moreau (3) , Azzouz Charrabi (3) , Yvonne Sleiman (3) , Albano C. Meli (3) , Gilles Millat (1, 4, 5) , Veronique Briand (2) , Philippe Beauverger (2) , Sylvain Richard (3) , Philippe Chevalier (1, 5)

1 INMG - Institut NeuroMyoGène
2 Sanofi Aventis R&D [Chilly-Mazarin]
3 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
4 HCL - Hospices Civils de Lyon
5 CBPE - Centre de Biologie et Pathologie Est

No abstract available

Domaines: Sciences du Vivant [q-bio]

Jean‐baptiste Reisqs, Adrien Moreau, Azzouz Charrabi, Yvonne Sleiman, Albano C. Meli, et al.. The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy. Clinical and Translational Medicine, 2022, 12 (3), ⟨10.1002/ctm2.748⟩. ⟨hal-03613345⟩